New Study Demonstrates Predictive Value of Lunit SCOPE IO to Predict Outcomes of Immune Checkpoint Inhibitor Therapy Across Diverse Tumors - published in the JITC
| Show full article |
|
This functionality is available for registred users only
|
-
Full nameLunit Inc.
-
IndustryMiscellaneous Healthcare: Products and Services
-
М/S&P/F
*** /*** /***









